logo

For the Inventor, By the Inventor

Longmont, CO, United States of America

Robert F Roscow

LinkedIn

This inventor holds 11 USPTO granted patents and 5 published patent applications. Top assignees: Mydecine Innovations Group Inc., Apoapsis Holdings, LLC, Other. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert F Roscow. Retrieved from https://idiyas.com/inventor/robert-f-roscow

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • Hamden, CT (US) (2004)
  • Longmont, CO (US) (2024)

Company Filing History:

goldMedal7 out of 7 
 
Mydecine Innovations Group Inc.
 patents
silverMedal3 out of 3 
 
Apoapsis Holdings, LLC
 patents
bronzeMedal1 out of 834,570 
Other
 patents

Years Active: 2004-2026

Loading Chart...
11 patents (USPTO):Explore Patents
1. 12759978 - Psilocin analog compositions and methods of synthesizing the same (2026-10-13),
2. 12708635 - Novel Formulations of Psilocybin And Psilocin Compounds as Serotonin Agonists in Combination With 3,4 Methylenedioxymethamphetamine (MDMA) (2026-08-18),
3. 12686660 - Aza-substituted psilocin analogs and methods of synthesizing the same (2026-07-21),
4. 12600708 - Prodrug compounds of 3,4-methylenedioxymethamphetamine (MDMA) and methods of synthesizing the same (2026-04-14),
5. 12570621 - Short-acting 3,4-methylenedioxymethamphetamine (MDMA) analogs incorporating benzothiazole (2026-03-10),
6. 12569466 - Short-acting psychoactive compounds of the MDMA class (2026-03-10),
7. 12064415 - Psilocin prodrug compounds and methods of synthesizing the same (2024-08-20),
8. 11952342 - Aza-substituted psilocin analogs and methods of synthesizing the same (2024-04-09),
9. 11939292 - Aza-substituted psilocin analogs and methods of synthesizing the same (2024-03-26),
10. 11896577 - Short-acting psychoactive compounds of the MDMA class (2024-02-13),
11. 6728996 - Adjustable liner retainer for containers (2004-05-04),

Title: The Innovative Contributions of Robert F. Roscow

Introduction

Robert F. Roscow is a notable inventor based in Longmont, Colorado. He has made significant contributions to the field of chemistry, particularly in the development of psilocin prodrug compounds. With a total of five patents to his name, Roscow's work showcases his dedication to advancing scientific knowledge and applications.

Latest Patents

Roscow's latest patents include innovative compounds and methods related to psilocin. One of his notable inventions is a class of psilocin carbamates and carbonate prodrug compounds that feature aza substitutions within the psilocin core. These psilocin prodrugs are designed to be enzymatically cleaved in vivo, offering potential therapeutic benefits. Another significant patent focuses on novel chemical compositions of psilocin analogs that possess enhanced physical and pharmacokinetic characteristics, along with methods for their synthesis.

Career Highlights

Throughout his career, Robert F. Roscow has worked with various organizations, including Mydecine Innovations Group Inc. His work in this company has allowed him to explore the therapeutic potential of psilocin and its derivatives, contributing to the growing field of psychedelic research.

Collaborations

Roscow has collaborated with esteemed colleagues such as Denton W. Hoyer and Rong Ling. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…